Viewing Study NCT04536792


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2026-02-17 @ 5:41 PM
Study NCT ID: NCT04536792
Status: COMPLETED
Last Update Posted: 2024-04-16
First Post: 2020-07-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease
Sponsor: Agios Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AG946-C-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators